Abstract

were asked to complete Accept and MMAS-4 questionnaires at Month 1, 3 and 6 after having given their informed consent. The structure was explored through PCA, and confirmed with multi-trait analysis. Internal consistency reliability of dimensions was assessed through Cronbach’s alpha. Scale-scale correlations were calculated. RESULTS: After reduction, Accept was made of 25 items organised in 1 overall Acceptance score and 6 domain-specific scores (efficacy, tolerance, convenience, constraints, treatment duration, multiple medication). Cronbach’s alpha was 0,85 for overall Acceptance score, which met convergent and divergent validity criteria (both 100%). The domain-specific scores showed satisfactory to good results (Cronbach’s alpha ranging from 0,67 0,87, convegrent validity ranging from 63% to 100%, and divergent validity ranging from 33% 100%). Scale-scale correlations ranged from 0.02 to 0.58, confirming the multi-dimensional nature of the questionnaire. The good properties of Accept were stable over time. CONCLUSIONS: Accept is a brief, comprehensive, generic questionnaire focused on Acceptance. Initial validation in a population of patients with a wide range of long-term treatment showed promising results and confirmed the position of Acceptance. Further, disease-specific, large prospective study are needed to assess the ability of Accept to predict persistence to treatment.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.